Edition:
India

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

5,530JPY
15 Nov 2018
Change (% chg)

-- (--)
Prev Close
¥5,530
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
96,049
52-wk High
¥6,600
52-wk Low
¥5,260

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Underperform -- March 16 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 2 2 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 4.00 4.00 4.00 4.00

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-18 2 99,750.00 100,200.00 99,300.00 --
Year Ending Mar-19 2 93,000.00 93,300.00 92,700.00 97,000.00
Year Ending Mar-20 2 92,700.00 93,200.00 92,200.00 97,950.00
Earnings (per share)
Year Ending Mar-18 2 490.65 491.10 490.20 --
Year Ending Mar-19 2 421.14 433.00 409.29 443.96
Year Ending Mar-20 2 427.24 437.60 416.88 453.87

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 21,845.00 20,249.00 1,596.00 7.31
Quarter Ending Dec-12 24,290.00 23,282.00 1,008.00 4.15
Quarter Ending Sep-12 22,719.00 22,742.00 23.00 0.10
Quarter Ending Jun-12 21,400.00 20,781.00 619.00 2.89

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-18 99,750.00 -- -- -- --
Year Ending Mar-19 93,000.00 93,000.00 93,100.00 93,100.00 97,000.00
Year Ending Mar-20 92,700.00 92,700.00 93,100.00 93,100.00 97,950.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 0 0 0 1
Year Ending Mar-20 0 0 0 1
Earnings